RNS Number : 4433S
Intl. Biotechnology Trust PLC
21 November 2011
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2011
|
Total net assets
|
£95.5m
|
|
NAV per share
|
171.3p
|
|
Share price
|
151.0p
|
|
Total value of unquoted investments
|
£17.5m
|
|
Total number of portfolio companies
|
68
|
|
Cash
|
3% NAV
|
|
Cash committed and reserved to unquoted investments
|
(9)% NAV
|
|
Portfolio companies with < 1 year of cash
|
13% NAV
|
Top Ten Holdings
|
Company Name
|
% NAV
|
|
Amgen
|
5.7
|
|
Teva
|
5.1
|
|
Gilead Sciences
|
4.5
|
|
Micromet
|
4.5
|
|
Insulet
|
4.1
|
|
Pharmaxis
|
3.7
|
|
Celgene
|
3.4
|
|
Shire
|
3.3
|
|
EUSA
|
3.0
|
|
Aptiv
|
2.9
|
|
|
-----------
|
|
Total
|
40.2
|
|
Geographical Allocation
|
%
|
|
United States
|
72
|
|
Europe
|
16
|
|
Israel
|
5
|
|
Australia
|
4
|
|
Cash
|
3
|
|
|
-----------
|
|
Total
|
100
|
|
Quoted/Unquoted allocation
|
%
|
|
Quoted
|
79
|
|
Unquoted
|
18
|
|
Cash
|
3
|
|
|
-----------
|
|
Total
|
100
|
BNP Paribas Secretarial Services Limited
Company Secretary
21 NOVEMBER 2011
This information is provided by RNS
The company news service from the London Stock Exchange
END
PFUGCBDBLUDBGBB